Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Olatropil®"'
Publikováno v:
Семейная медицина, Vol 0, Iss 2, Pp 33-40 (2018)
The article is devoted to the actual problem of modernity – chronic cerebrovascular pathology. The data on efficacy of therapy with combined nootropic Olatropyl are presented in comparison with piracetam in patients with chronic brain ischaemia due
Publikováno v:
Семейная медицина, Vol 0, Iss 1(63), Pp 96-100 (2016)
Actuality: there are more than 12 million people with hypertension and more than 3 million with chronic cerebrovascular disease in Ukraine. This increases the quantity of patients with cognitive deficits and impairs the quality of life of patients wi
Autor:
Мамчур, В. И.1 vmamchur@dma.dp.ua, Дронов, С. Н.1
Publikováno v:
Medical Perspectives / Medičnì Perspektivi. 2018, Vol. 23 Issue 3, p4-12. 9p.
Autor:
V. I. Mamchur, S. N. Dronov
Publikováno v:
Medičnì Perspektivi, Vol 23, Iss 3, Pp 4-12 (2018)
Optimization of pharmacotherapy of neurological and psychosomatic diseases led to the creation of combined medicines containing two or more components with different mechanisms of action, differently affecting the pathogenesis and clinical manifest
Externí odkaz:
https://doaj.org/article/c7f6a7720d0045fe82da5d1e6f581721
Publikováno v:
Mezdunarodnyj Nevrologiceskij Zurnal; 2018, Vol. 101 Issue 7, p49-55, 7p
Autor:
S. N. Dronov, V. I. Mamchur
Publikováno v:
Medicni perspektivi (Medical perspectives); Том 23, № 3 (2018); 4-12
Медичні перспективи; Том 23, № 3 (2018); 4-12
Medičnì Perspektivi, Vol 23, Iss 3, Pp 4-12 (2018)
Медичні перспективи; Том 23, № 3 (2018); 4-12
Medičnì Perspektivi, Vol 23, Iss 3, Pp 4-12 (2018)
Optimization of pharmacotherapy of neurological and psychosomatic diseases led to the creation of combined medicines containing two or more components with different mechanisms of action, differently affecting the pathogenesis and clinical manifest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::459dc17b026c3b57ca8218fe5fe17265
https://zenodo.org/record/2577877
https://zenodo.org/record/2577877
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL; № 7.101 (2018); 49-55
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; № 7.101 (2018); 49-55
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; № 7.101 (2018); 49-55
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; № 7.101 (2018); 49-55
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; № 7.101 (2018); 49-55
The evolution of drugs in the 21st century was marked by a significant increase in the requirements for their efficacy and safety. At the same time, a rather limited range of drugs, in particular nootropics with truly unique clinical and pharmacologi
Publikováno v:
Family Medicine; № 2 (2018); 33-40
Семейная медицина; № 2 (2018); 33-40
Сімейна медицина; № 2 (2018); 33-40
Семейная медицина; № 2 (2018); 33-40
Сімейна медицина; № 2 (2018); 33-40
The article is devoted to the actual problem of modernity – chronic cerebrovascular pathology. The data on efficacy of therapy with combined nootropic Olatropyl are presented in comparison with piracetam in patients with chronic brain ischaemia due
Publikováno v:
Family Medicine; № 3(71) (2017); 104-112
Семейная медицина; № 3(71) (2017); 104-112
Сімейна медицина; № 3(71) (2017); 104-112
Семейная медицина; № 3(71) (2017); 104-112
Сімейна медицина; № 3(71) (2017); 104-112
Цель исследования: оценка влияния фиксированной комбинации ноотропного препарата Олатропил® на нейровегетативные, психоэмоциональны
Publikováno v:
Семейная медицина, Vol 0, Iss 3(71), Pp 104-112 (2017)
Цель исследования : оценка влияния фиксированной комбинации ноотропного препарата Олатропил® на нейровегетативные, психоэмоциональны